(Q37038910)

17 August 2017

1 reference

title

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer (English)

1 reference

Adaptive radiation therapy

17 August 2017

main subject

0 references

1 reference

Simon S Lo

1

1 reference

17 August 2017

Achilles J Fakiris

2

1 reference

17 August 2017

Lech Papiez

3

1 reference

17 August 2017

Ramzi Abdulrahman

4

1 reference

17 August 2017

Ronald C McGarry

5

1 reference

17 August 2017

Mark A Henderson

6

1 reference

17 August 2017

Jeffrey A Forquer

7

1 reference

17 August 2017

David Hoopes

8

1 reference

17 August 2017

Robert D Timmerman

9

1 reference

17 August 2017

publication date

1 January 2008

1 reference

Expert Review of Anticancer Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

87-98

1 reference

Stereotactic body radiation therapy in multiple organ sites

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

A new international staging system for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Radiation therapy for medically inoperable stage I and II non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac-based stereotactic radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Loss of biological effect in prolonged fraction delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Optimization of radiation therapy: integral-response of a model biological system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Reproducibility of organ position using voluntary breath-hold method with spirometer for extracranial stereotactic radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Infrared patient positioning for stereotactic radiosurgery of extracranial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Determining parameters for respiration-gated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Real-time tumour-tracking radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Respiration tracking in radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Benefit of three-dimensional image-guided stereotactic localization in the hypofractionated treatment of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

The North American experience with stereotactic body radiation therapy in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.87

21 January 2018

Identifiers

DOI

10.1586/14737140.8.1.87

1 reference

17 August 2017

1 reference